Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)

On January 21, 2023, Marianne De Backer, Ph.D., notified us of her decision to resign from our board of directors as a result of her recent appointment as Chief Executive Officer of Vir Biotechnology, Inc., and in consideration of her additional time commitments associated with such position, as well as the "overboarding" policies of shareholder advisory firms. The effective date of the resignation has not yet been established, but Dr. De Backer informed us it would likely be late in the first quarter or in the second quarter of 2023. We will file an amendment to this current report on Form 8-K to report the effective date of Dr. De Backer's resignation within four business days of the effective date being determined.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses